Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile

European Journal of Endocrinology

Volumn 159, Issue 3, 2008, Pages 259-274

  Lourenco Jr D M ^a   Toledo, R A ^a   Mackowiak, I I ^a   Coutinho, F L ^a   Cavalcanti, M G ^a   Correia Deur, J E M ^a   Montenegro, F ^a   Siqueira, S A C ^a   Margarido, L C ^a   Machado, M C ^a   Toledo, S P A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 PROTEIN; UNCLASSIFIED DRUG; MEN1 PROTEIN, HUMAN; ONCOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; BRAZIL; CANCELLOUS BONE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEMUR NECK; GENE MUTATION; GENETIC RISK; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; HYPERPARATHYROIDISM; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; OSTEOLYSIS; OSTEOPOROSIS; PEDIGREE; PREVALENCE; PRIORITY JOURNAL; PROLACTINOMA; TISSUE DISTRIBUTION; TUMOR CLASSIFICATION; FAMILY; FOUNDER EFFECT; GENETICS; GEOGRAPHY; HAPLOTYPE; HYPERTHYROIDISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; BONE DENSITY; BRAZIL; DNA MUTATIONAL ANALYSIS; FAMILY; FEMALE; FOUNDER EFFECT; GEOGRAPHY; GERM-LINE MUTATION; HAPLOTYPES; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PEDIGREE; PROTO-ONCOGENE PROTEINS;

EID: 53249109898     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-08-0153     Document Type: Article

References (54)

1. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr & Marx SJ. Guidelines for diagnosis and therapy of MEN type 1 and type 2. Journal of Clinical Endocrinology and Metabolism 2001 86 5658-5671.
2. Marx SJ. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nature Reviews. Cancer 2005 5 367-375.
3. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Hcppner C, Dong Q, Spiegel AM, Burns AL & Marx SJ. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997 276 404-407.
4. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautout V, Buisson N, De Witte K, Salandre J, Lenoir G, Pugeat M, Calender A, Parente F, Quincey D, Gaudray P, De Wit MJ, Lips CJ, Hoppener JW, Khodaei S, Grant AL, Weber G, Kytola S, Teh BT, Farnebo F, Phelan C, Hayward N, Larsson C, Pannet AA, Forbes SA, Bassett JH & Thakker RV. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Human Molecular Genetics 1997 6 1177-1183.
5. Agarwal SK, Kennedy PA, Scacheri PC, Novotny EA, Hickman AB, Cerrato A, Rice TS, Moore JB, Rao S, Ji Y, Mateo C, Libutti SK, Oliver B, Chandrasekharappa SC, Burns A, Collins FS, Spiegel AM & Marx SJ. Menin molecular interactions: insights into normal functions and tumorigenesis. Hormone and Metabolic Research 2005 37 369-374.
6. Kouvaraki MA, Lee JR, Shapiro SE, Gagel RF. Sherman SI, Sellin RV, Cote GJ & Evans DB. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Archives of Surgery 2002 137 641-647.
7. Wautot V, Vercherat C, Lespinasse J, Chambe B, Lenoir GM, Zhang CX, Porchet N, Cordler M, Beroud C & Calender A. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. Human Mutation 2002 20 35-47.
8. Ellard S, Hattersley AT, Brewer CM & Vaidya B. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing. Clinical Endocrinology 2005 62 169-175.
9. Lemos MC & Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Human Mutation 2008 29 22-32.
10. Benson L, Ljunghall S, Akerstrom G & Oberg K. Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. American Journal of Medicine 1987 82 731-737.
11. Carty SE, Helm AK, Amico JA, Clarke MR, Foley TP, Watson CG & Mulvihill JJ. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 1998 124 1106-1113.
12. Green JS, Rigatto C, Parfrey PS, Kaiser SM, Galway AB, Joyce CJ, Galway A, Joyce C & Ur E. MEN-1 (Burin): update on a unique phenotypic variant. (Abstract) American Journal of Human Genetics 1999 65 (Suppl 1) A128.
13. Marx SJ, Vinik AI, Santen RJ, Floyd JC Jr, Mills JL & Green J III. Multiple endocrine neoplasia type I: assessment of laboratory tests to screen for the gene in a large kindred. Medicine 1986 65 226-241.
14. Olufemi SE, Green JS, Manickam P, Guru SC, Agarwal SK, Kester MB, Dong Q, Burns AL, Spiegel AM, Marx SJ, Collins FS & Chandrasekharappa SC. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland. Human Mutation 1998 11 264-269.
15. Vasen HF, Lamers CB & Lips CJ. Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands. Archives of Internal Medicine 1989 149 2717-2722.
16. Skogseid B, Eriksson B, Lundqvist G, Lorelius LE, Rastad J, Wide L, Akerstrom G & Oberg K. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. Journal of Clinical Endocrinology and Metabolism 1991 73 281-287.
17. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, Lips K, Monson JP, O'Halloran D, Sampson J, Shalet SM, Wheeler MH, Zink A & Thakker RV. Clinical studies of multiple endocrine neoplasia. type 1 (MEN1). Quarterly Journal of Medicine 1996 89 653-669.
18. Kopp I, Bartsch D, Wild A, Schilling T, Nies C, Bergenfelz A, Rieder H, Simon B & Rothmund M. Predictive genetic screening and clinical findings in multiple endocrine neoplasia type I families. World Journal of Surgery 2001 25 610-616.
19. Verges B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe B, Montvernay C & Calender A. Pituitary disease in MEN type 1 (MEN1): data from the France - Belgium MEN1 multicenter study. Journal of Clinical Endocrinology and Metabolism 2002 87 457-465.
20. Teh BT, Esapa CT, Houlston R, Grandell U, Farnebo F, Nordenskjold M, Pearce CJ, Carmichael D, Larsson C & Harris PE. A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. American Journal of Human Genetics 1998 63 1544-1549.
21. Kassem M, Kruse TA, Wong FK, Larsson C & Teh BT. Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree. Journal of Clinical Endocrinology and Metabolism 2000 85 165-167.
22. Villablanca A, Wassif WS, Smith T, Hoog A, Vierimaa O, Kassem M, Dwight T, Du Forsberg LQ, Learoyd D, Jones K, Stranks S, Juhlin C, Teh BT, Carling T, Robinson B & Larsson C. Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism. European Journal of Endocrinology 2002 147 313-322.
23. Hannan FM, Nesbit MA, Christie PT, Fratter C, Dudley NE, Sadler GP & Thakker RV. Familial isolated primary hyperparathyroidism caused by mutations of the MEN1 gene. Nature Clinical Practice. Endocrinology & Metabolism 2008 4 53-58.
24. Hao W Skarulis MC, Simonds WE, Weinstein LS, Agarwal SK, Mateo C, James-Newton L, Hobbs GR, Gibril F, Jensen RT & Marx SJ. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma. Journal of Clinical Endocrinology and Metabolism 2004 89 3776-3784.
25. Shepherd JJ. The natural history of multiple endocrine neoplasia type 1. Archives of Surgery 1991 126 935-952.
26. Vierimaa O, Ebeling TM, Kytölä S, Bloigu R, Eloranta E, Salmi J, Korpi-Hyövälti E, Niskanen L, Orvola A, Elovaara E, Gynther A, Sane T, Välimäki M, Ignatius J, Leisti J & Salmela PI. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation. European Journal of Endocrinology 2007 157 285-294.
27. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L & Greenaway TM. Somatotrophinomas in multiple endocrine neoplasia type 1: a review of clinical phenotype and insulin-like growth factor-1 levels in a large multiple endocrine neoplasia type 1 kindred. American Journal of Medicine 1996 100 544-547.
28. Agarwal SK, Debelenko LV, Kester MB, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Heppner C, Crabtree JS, Lubensky IA, Zhuang Z, Kim YS, Chandrasekharappa SC, Collins FS, Liotta LA, Spiegel AM, Burns AL, Emmert-Buck MR & Marx SJ. Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families. Human Mutation 1998 12 75-82.
29. Burgess JR, Nord B, David R, Greenaway TM, Parameswaran V, Larsson C, Shepherd JJ & Teh BT. Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1). Clinical Endocrinology 2000 53 205-211.
30. Kytölä S, Villablanca A, Ebeling T, Nord B, Larsson C, Höög A, Wong FK, Välimäki M, Vierimaa O, Teh BT, Salmela PI & Leisti J. Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland. Journal of Medical Genetics 2001 38 185-189.
31. Burgess JR, David R, Greenaway TM, Parameswaran V & Shepherd JJ. Osteoporosis in multiple endocrine neoplasia type 1. Archives of Surgery 1999 134 1119-1123.
32. Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao IC, Waguespack SG, Gagel RF, Evans DB & Perrier ND. Management of pancreatic endocrine tumors in multiple endocrine neoplasia. type 1. World Journal of Surgery 2006 30 643-653.
33. Toledo RA, Lourenco DM, Coutinho FL, Quedas E, Mackowiack I, Machado MC, Montenegro F, Cunha-Neto MB, Liberman B Pereira MA, Correa PH & Toledo SP. Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1. Clinical Endocrinology 2007 67 377-384.
34. Lourenço-Jr DM, Toledo RA, Coutinho FL, Margarido LC, Siqueira SA, dos Santos MA, Montenegro FL, Machado MC & Toledo SP. The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1. Clinics 2007 62 465-476.
35. WHO. Technical Report Series 1994 843 5-48.
36. Waterlot C, Porchet N, Bauters C, Decoulx M, Wemeau JL, Proye C, Degand PM, Aubert JP, Cortet C & Dewailly D. Type 1 multiple endocrine neoplasia (MENI): contribution of genetic analysis to the screening and follow-up of a large French kindred. Clinical Endocrinology 1999 51 101-107.
37. Giraud S, Choplin H, Tch BT, Lespinasse J, Jouvet A, Labat-Moleur F, Lenoir G, Hamon B, Hamon P & Calender A. A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation. Journal of Clinical Endocrinology and Metabolism 1997 82 3487-3492.
38. Abe T, Yoshimoto K, Taniyama M, Hanakawa K, Izumiyama H, Itakura M & Matsumoto K. An unusual kindred of the multiple endocrine neoplasia type 1 in Japanese. Journal of Clinical Endocrinology and Metabolism 2000 85 1327-1330.
39. Kong C, Ellard S, Johnston C & Farid NR. Multiple endocrine neoplasia type 1 (Burin) from Mauritius: a novel MEN 1 mutation. Journal of Endocrinological Investigation 2001 24 806-810.
40. Akerström G, Hessman O, Hellman P & Skogseid B. Pancreatic tumours as part of the MEN-1 syndrome. Best Practice and Research. Clinical Endocrinology and Metabolism 2005 19 819-830.
41. Anlauf M, Garbrecht N, Henopp T, Schmitt A, Schlenger R, Raffel A, Krausch M, Gimm O, Eisenberger CF, Knoefel WT, Dralle H, Komminoth P, Heitz PU, Perren A & Klöppel G. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World Journal of Gastroenterology 2006 12 5440-5446.
42. Thomas-Marques L, Murat A, Delemer B, Penfornis A, Cardot-Bauters C, Baudin E, Niccoli-Sire P, Levoir D, Choplin Hdu B, Chabre O, Jovenin N & Cadiot G. Groupe dcs Tumeurs Endocrines (GTE). Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. American Journal of Gastroenterology 2006 101 266-273.
43. Dreijerink KM, Van Beek AP, Lentjes EG, Post JG, Van der Luijt RB, Canninga-Van Dijk MR & Lips CJ. Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease. European Journal of Endocrinology 2005 153 741-746.
44. Silverberg SJ, Shane E, De La Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV, Lindsay R, Clemens TL & Bilezikian JP. Skeletal disease in primary hyperparathyroidism. Journal of Bone and Mineral Research 1989 4 283-291.
45. Bilezikian JP, Brandi ML, Rubin M & Silverberg SJ. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. Journal of Internal Medicine 2005 257 6-17.
46. Silverberg SJ, Locker FG & Bilezikian JP. Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 1996 81 4007-4012.
47. Sowa H, Kaji H, Canaff L, Hendy GN, Tsukamoto T, Yamaguchi T, Miyazono K, Sugimoto T & Chihara K. Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage. Journal of Biological Chemistry 2003 278 21058-21069.
48. Morelli A, Falchetti A, Martineti V, Becherini L, Mark M, Friedman E & Brandi ML. MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1. European Journal of Endocrinology 2000 142 131-137.
49. Giraud S, Zhang CX, Serova-Sinilnikova O, Wautot V, Salandre J, Buisson N, Waterlot C, Bauters C, Porchet N, Aubert JP, Emy P, Cadiot G, Delcmer B, Chabre O, Niccoli P, Leprat F, Duron F, Emperauger B, Cougard P, Goudet P, Sarfati E, Riou JP, Guichard S, Rodier M & Calender A. Germline mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. American Journal of Human Genetics 1998 63 455-467.
50. Cardinal JW, Bergman L, Hayward N, Sweet A, Warner J, Marks L, Learoyd D, Dwight T, Robinson B, Epstein M, Smith M, Teh BT, Cameron DP & Prins JB. A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. Journal of Medical Genetics 2005 42 69-74.
51. Tham E, Grandell U, Lindgren E, Toss G, Skogseid B & Nordenskjöld M. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. Journal of Clinical Endocrinology and Metabolism 2007 92 3389-3395.
52. Cetani F, Pardi E, Cianferotti L, Vignali E, Picone A, Miccoli P, Pinchera A & Marcocci C. A new mutation of the MEN1 gene in an italian kindred with multiple endocrine neoplasia type 1. European Journal of Endocrinology 1999 140 429-433.
53. Asteria C, Faglia G, Roncoroni R, Borretta G, Ribotto P & Beck-Peccoz P. Identification of three novel menin mutations (c.741delGTCA, c.1348T>C, c.1785delA) in unrelated Italian families affected with multiple endocrine neoplasia type 1: additional information for mutational screening. Human Mutation 2001 17 237.
54. Nuzzo V, Tauchmanová L, Falchetti A, Faggiano A, Marini F, Piantadosi S, Brandi ML, Leopaldi L & Colao A. MEN1 family with a novel frameshift mutation. Journal of Endocrinological Investigation 2006 29 450-456.